Insider · CIK 0001539494

Martin Tami Tillotson

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001539494

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. V.P., Regulatory Affairs	AAward	+1,250 sh	—	—	87,418
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. V.P., Regulatory Affairs	FTax Payment	−485 sh	$29.06	−$14.1K	86,933
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Sr. V.P., Regulatory Affairs	DDisposition to Issuer	−1,250 sh	—	—	3,750
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. V.P., Regulatory Affairs	AAward	+750 sh	—	—	86,414
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. V.P., Regulatory Affairs	FTax Payment	−246 sh	$27.94	−$6,873.24	86,168
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Sr. V.P., Regulatory Affairs	DDisposition to Issuer	−750 sh	—	—	1,500
2024-01-10	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+8,000 sh	$9.24	+$73.9K	93,664
2024-01-10	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−8,000 sh	$27.91	−$223K	85,664
2024-01-10	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−8,000 sh	—	—	0
2023-08-30	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+8,100 sh	$23.99	+$194K	93,349
2023-08-30	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−8,100 sh	$32.00	−$259K	85,249
2023-08-30	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−8,100 sh	—	—	13,900
2023-08-25	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−5,135 sh	$31.59	−$162K	85,249
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. V.P., Regulatory Affairs	AAward	+20K sh	—	—	20,000
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Sr. V.P., Regulatory Affairs	AAward	+5,000 sh	—	—	5,000
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. V.P., Regulatory Affairs	AAward	+750 sh	—	—	90,323
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Sr. V.P., Regulatory Affairs	DDisposition to Issuer	−750 sh	—	—	2,250
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Sr. V.P., Regulatory Affairs	AAward	+750 sh	—	—	90,323
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.F Tax Payment	Sr. V.P., Regulatory Affairs	FTax Payment	−289 sh	$38.57	−$11.1K	90,034
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Sr. V.P., Regulatory Affairs	DDisposition to Issuer	−750 sh	—	—	2,250
2023-02-16	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+1,500 sh	—	—	88,720
2023-02-16	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitM Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−1,500 sh	—	—	0
2023-01-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Performance Share UnitA Award	Sr. V.P., Regulatory Affairs	AAward	+1,500 sh	—	—	1,500
2022-08-22	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+5,000 sh	$7.90	+$39.5K	92,220
2022-08-22	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−5,000 sh	$35.98	−$180K	87,220
2022-08-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−5,000 sh	—	—	0
2022-08-04	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+5,000 sh	$7.90	+$39.5K	92,220
2022-08-04	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−5,000 sh	$32.98	−$165K	87,220
2022-08-04	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−5,000 sh	—	—	5,000
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. V.P., Regulatory Affairs	AAward	+18K sh	—	—	18,000
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Sr. V.P., Regulatory Affairs	AAward	+3,000 sh	—	—	3,000
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. V.P., Regulatory Affairs	AAward	+18K sh	—	—	18,000
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Sr. V.P., Regulatory Affairs	AAward	+3,000 sh	—	—	3,000
2021-04-14	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+3,125 sh	$12.98	+$40.6K	89,451
2021-04-14	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−3,125 sh	$31.98	−$99.9K	86,326
2021-04-14	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−3,125 sh	—	—	6,250
2021-04-13	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+3,125 sh	$12.98	+$40.6K	89,451
2021-04-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Sr. V.P., Regulatory Affairs	SSale	−3,125 sh	$29.98	−$93.7K	86,326
2021-04-13	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−3,125 sh	—	—	9,375
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. V.P., Regulatory Affairs	AAward	+17K sh	—	—	17,000
2020-02-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Sr. V.P., Regulatory Affairs	AAward	+22K sh	—	—	22,000
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+37.5K sh	$1.60	+$60K	40,000
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+1,250 sh	$3.36	+$4,200	41,250
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	+9,375 sh	$2.56	+$24K	50,625
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−37.5K sh	—	—	0
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−1,250 sh	—	—	1,250
2012-12-12	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	Sr. V.P., Regulatory Affairs	MExercise/Conversion	−9,375 sh	—	—	28,125
2012-05-04	SUPNSUPERNUS PHARMACEUTICALS, INC.P Purchase	Sr. V.P., Regulatory Affairs	PPurchase	+2,500 sh	$5.00	+$12.5K	2,500

Recent filings

Accepted (ET)
Feb 274
Martin Tami Tillotson0001104659-24-028269
SEC(opens sec.gov)
Feb 264
Martin Tami Tillotson0001104659-24-027564
SEC(opens sec.gov)
Jan 124
Martin Tami Tillotson0001104659-24-003741
SEC(opens sec.gov)
Sep 14
Martin Tami Tillotson0001104659-23-097813
SEC(opens sec.gov)
Aug 294
Martin Tami Tillotson0001104659-23-096582
SEC(opens sec.gov)
Apr 124/A
Martin Tami Tillotson0001104659-23-044664
SEC(opens sec.gov)
Feb 274
Martin Tami Tillotson0001104659-23-026085
SEC(opens sec.gov)
Feb 244
Martin Tami Tillotson0001104659-23-025370
SEC(opens sec.gov)

Companies

SUPERNUS PHARMACEUTICALS, INC.Sr. V.P., Regulatory AffairsSUPN

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850